The NRG1-ErbB4 signaling pathway may be a new target for the activation of PAV-positive neurons via the NRG1/ErbB4 pathway and suppression of RAP-induced GP activation, atrial electrical remodeling and AF. The gene discussed is LRPAP1; the disease is atrial fibrillation.